University Hospital Lausanne, CHUV
University Hospital Lausanne, CHUV
Lausanne, Switzerland1 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Pembrolizumab for Newly Diagnosed Glioblastoma | Newly Diagnosed Glioblastoma | Active, not recruiting | Phase 2 | 2024-05-08 | NCT03899857 |